Northland Capmk Estimates Arteris’ Q1 Earnings (NASDAQ:AIP)

Arteris, Inc. (NASDAQ:AIP) – Equities researchers at Northland Capmk issued their Q1 2026 earnings per share (EPS) estimates for Arteris in a research note issued to investors on Wednesday, February 19th. Northland Capmk analyst G. Richard forecasts that the company will earn ($0.14) per share for the quarter. The consensus estimate for Arteris’ current full-year earnings is ($0.71) per share. Northland Capmk also issued estimates for Arteris’ Q2 2026 earnings at ($0.11) EPS, Q3 2026 earnings at ($0.10) EPS and Q4 2026 earnings at ($0.07) EPS.

A number of other research firms also recently issued reports on AIP. Northland Securities boosted their target price on shares of Arteris from $14.00 to $16.00 and gave the company an “outperform” rating in a research report on Wednesday. Rosenblatt Securities reiterated a “buy” rating and set a $15.00 price objective on shares of Arteris in a report on Tuesday.

Arteris Price Performance

Shares of AIP opened at $9.85 on Friday. Arteris has a 52-week low of $5.76 and a 52-week high of $12.64. The business’s 50 day moving average price is $10.55 and its two-hundred day moving average price is $8.71. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.17 and a quick ratio of 1.16.

Arteris (NASDAQ:AIP) last announced its quarterly earnings data on Tuesday, February 18th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.08). Arteris had a negative net margin of 58.27% and a negative return on equity of 828.71%. The business had revenue of $15.49 million during the quarter, compared to analyst estimates of $15.34 million.

Insider Buying and Selling

In other news, Director Saiyed Atiq Raza sold 12,166 shares of the stock in a transaction that occurred on Wednesday, December 18th. The stock was sold at an average price of $10.07, for a total value of $122,511.62. Following the completion of the sale, the director now directly owns 731,560 shares of the company’s stock, valued at $7,366,809.20. This represents a 1.64 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Nicholas B. Hawkins sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $8.56, for a total value of $42,800.00. Following the completion of the transaction, the chief financial officer now owns 190,414 shares in the company, valued at $1,629,943.84. This represents a 2.56 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 367,157 shares of company stock worth $3,828,388 in the last ninety days. Corporate insiders own 33.70% of the company’s stock.

Institutional Investors Weigh In On Arteris

Institutional investors and hedge funds have recently bought and sold shares of the stock. US Bancorp DE bought a new stake in shares of Arteris in the 3rd quarter worth $34,000. Quarry LP purchased a new position in Arteris during the fourth quarter worth about $46,000. R Squared Ltd bought a new stake in Arteris in the 4th quarter worth about $64,000. D. E. Shaw & Co. Inc. bought a new stake in Arteris in the 4th quarter worth about $110,000. Finally, Price T Rowe Associates Inc. MD purchased a new stake in Arteris in the 4th quarter valued at about $117,000. 64.36% of the stock is owned by hedge funds and other institutional investors.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.